![](/documents/10803/1014936/Research+suggests+greater+access+to+specific+HIV+and+tuberculosis+medications+is+needed+worldwide+thumbnail.jpg/63723583-8675-f810-4f52-b4a6c12d9e90?t=1598368095118)
Research suggests greater access to specific HIV and tuberculosis medications is needed worldwide
Postdoctoral fellows at the RI-MUHC carried out primary statistical analyses for study published in The Lancet
![](/documents/10803/1014936/Inappropriate+prescriptions+sending+hospitalized+seniors+back+to+the+ER+thumbnail.jpg/988c4386-5fad-4634-b117-5fd8d057e90a?t=1597260594276)
Inappropriate prescriptions sending hospitalized seniors back to the ER
Improving hospital prescribing practices may reduce risk of rehospitalization and death
![](/documents/10803/1014141/Canada+Research+Chairs+Program+announces+new+and+renewed+chairs+thumbnail.jpg/964b7410-9d6b-d68d-9474-636e03fa0355?t=1596737371968)
Canada Research Chairs Program announces new and renewed chairs
Congratulations to five RI-MUHC researchers in the spring 2020 round!
![](/documents/10803/1000651/With+Veterans+Affairs+Canada%2C+Dr.+Steven+Grover+and+his+team+are+getting+Canadian+families+moving+thumbnail.jpg/ddef39b0-673b-b4c5-49dd-d07906b80f9c?t=1595263893335)
With Veterans Affairs Canada, Dr. Steven Grover and his team are getting Canadian families moving
The summer Family Fitness Mission
![](/documents/10803/987147/Early+treatment+trial+of+hydroxychloroquine+shows+no+symptomatic+benefit+for+COVID-19+patients+tumbnail.png/50ee39fa-6ccf-588c-29ad-1e392d468874?t=1594996005809)
Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients
Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine
![](/documents/10803/993134/Mikashmi-thumbnail.jpg)
Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli
A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics
![](/documents/10803/941785/Three+COVID-19+projects+at+the+RI-MUHC+to+receive+CIHR+funding+thumbnail.jpg/35299054-b9e1-cf5e-72b3-82cb85e06725?t=1593193199353)
Three COVID-19 projects at the RI-MUHC to receive CIHR funding
A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease
![](/documents/10803/946541/COVID-19+pandemic+Looking+back+to+better+tackle+future+challenges+thumbnail.jpg/41d85882-0c2c-440e-500f-3c833a2f243b?t=1593091160157)
COVID-19 pandemic: Looking back to better tackle future challenges
In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies
![](/documents/10803/946541/Rifampin+for+Latent+TB+Shorter+and+safer+than+the+standard+treatment%2C+but+also+cheaper+thumbnail.jpg/354075da-d64f-f8bf-9784-4c73dfa292c3?t=1592425697161)
Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper
A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis
![](/documents/10803/946541/COVID-19+pandemic+the+need+for+privacy+and+digital+contact+tracing+thumbnail.jpg/1ad12dec-d683-8f76-f0ee-23f0853bf6b1?t=1591902357240)
COVID-19 pandemic: the need for privacy and digital contact tracing
RI-MUHC researcher Abhinav Sharma calls for an approach emphasizing voluntary consent